Pooled results on targeted drugs for lung cancer that spread to the brain
Original title: Systemic and intracranial activity of antibody-drug conjugates in patients with non-small cell lung cancer and brain metastases: A systematic review and meta-analysis.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This pools results from earlier studies in people, but it is not proven care for brain spread.
The short version
Researchers pooled past studies to see if these drugs help when lung cancer spreads to the brain.
What was studied. Researchers pooled 13 studies of antibody drug conjugates in people with non-small cell lung cancer. The studies had 3,191 patients, and 905 had cancer that had spread to the brain.
What they found. Tumors in the body got smaller in 40% of patients. Tumors in the brain got smaller in 33%. Drugs aimed at a target called HER2 did better, with 54% in the body and 44% in the brain. Growth was held in check in 77% of patients in the body and 78% in the brain.
What this means, and what it doesn't
What it could mean: If lung cancer has spread to your brain, these drugs may still do something. It is worth asking your cancer team if one of them fits your tumor.
What it doesn't mean: This is not a new drug and it is not a cure. It is a look back at past studies, not one new trial. Only some of the patients in those studies had cancer in the brain. It does not promise this will work for any one person, and it does not change what your doctor can offer you today.
Source: PubMed, September 28, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.